reach: hydroxyurea for sickle cell anemia in sub-saharan africa
Published 5 years ago • 406 plays • Length 5:57Download video MP4
Download video MP3
Similar videos
-
2:47
genetic modifiers affecting the response to hydroxyurea in children with sickle cell anemia
-
1:35
the mechanism of action of hydroxyurea in scd
-
2:10
hydroxyurea for sickle cell anemia
-
2:16
determining when to switch from hydroxyurea to interferon-based therapy in patients with pv
-
1:07
developing a test for sickle cell disease
-
1:36
the limitations and future of precision medicine in sickle cell disease
-
1:53
sickle cell disease: an overview and future therapies
-
3:59
sickle cell anemia
-
1:10
upcoming novel agents for the treatment of sickle cell disease
-
2:08
new agents under investigation in sickle cell disease
-
8:53
sickle cell anemia - causes, symptoms, diagnosis, treatment & pathology
-
1:11
precision medicine in sickle cell disease: current status and future outlooks
-
1:43
the role of complement activation in complications of sickle cell disease
-
1:17
novel biomarkers and emerging therapies for sickle cell disease
-
1:59
prospective study evaluating complement activation in patients with sickle cell disease
-
2:32
effectiveness of hydroxycarbamide in pediatric scd in the real world
-
1:53
novel agents for sickle cell disease
-
1:12
working towards health equity in sickle cell disease: addressing discrimination and bias
-
1:26
improving outcomes in sickle cell disease: expanding access and expediting treatment development